Latest Research Highlights (UK + EU, 2022–2025)

Basic Levitra Super Force Information

• INN (International Nonproprietary Name): Vardenafil.
• Brand Names Available In United Kingdom: Levitra — tablets 5 mg, 10 mg and 20 mg.
• ATC Code: G04BE09.
• Forms & Dosages: Tablets containing 5 mg, 10 mg and 20 mg vardenafil hydrochloride.
• Manufacturers In United Kingdom: Original manufacturer Bayer AG with co‑marketing by GSK; regional licensees and generics supplied by various manufacturers.
• Registration Status In United Kingdom: Levitra (vardenafil) is authorised by the MHRA for erectile dysfunction.
• OTC / Rx Classification: Prescription only (Rx) for vardenafil preparations; "Super Force" combination products are not registered.

What does recent European research say about vardenafil and combination products?

Systematic reviews and observational cohorts conducted across the UK and EU from 2022 to 2025 reaffirm vardenafil's effectiveness for erectile dysfunction compared with placebo and produce comparable short‑term response rates to sildenafil.

Onset of effect is generally reported between 30 and 60 minutes with peak effect around one hour, which aligns with pharmacokinetic expectations for vardenafil tablets.

Randomised trials and meta‑analyses demonstrate improvements in International Index of Erectile Function (IIEF) scores versus placebo in adult men with ED.

Adverse events in trial reports are dominated by headache, flushing and dyspepsia, reported at higher rates than placebo but generally mild to moderate.

EU pharmacovigilance updates and case series summarise rare cardiovascular cautions and occasional visual disturbances as signals requiring clinical caution.

Combination therapy data from trials pairing PDE5 inhibitors with dapoxetine show improved ejaculatory latency for men with comorbid premature ejaculation.

Regulatory bodies such as the MHRA and EMA have not authorised any fixed branded combination of vardenafil plus dapoxetine, and "Levitra Super Force" is not an authorised product but an unregistered online combination frequently encountered in e‑marketplaces.

Data highlights from recent literature emphasise clinically meaningful IIEF improvements and absolute adverse‑event rates dominated by headache and flushing.

Signal strength for visual symptoms and cardiovascular events remains low but sufficient to warrant screening for cardiac risk factors before prescribing.

In combination therapy trials, adding dapoxetine to a PDE5 inhibitor improves ejaculatory latency, but fixed combinations are not approved and must only be used as separate prescriptions if clinically indicated.

Clinical Effectiveness In The UK

Does vardenafil work in NHS practice and what do patients report?

Vardenafil, marketed as Levitra, is used on‑demand in NHS urology and sexual‑health clinics and shows documented improvements in erectile function and patient satisfaction.

Rapid onset is commonly cited by patients as helpful for spontaneity, which supports adherence in many cases.

Effectiveness can be reduced in men with severe vascular disease or following radical prostatectomy, where endothelial or nerve damage limits response.

Side effects and mismatched expectations are frequent reasons for discontinuation in real‑world use, and pharmacy counselling improves persistence.

• IIEF change: consistent improvement versus baseline in NHS audits and clinic reports.
• Responder rate: comparable short‑term responder rates to sildenafil in head‑to‑head practice observations.
• Common AEs: headache, flushing and dyspepsia are the most reported in clinics.

In practice, elderly men and those with liver impairment are started at lower doses in line with MHRA guidance to reduce exposure and side‑effects.

Indications And Expanded Uses

What is vardenafil licensed for and how is it used off‑label in the UK?

The MHRA‑approved indication for vardenafil is erectile dysfunction in adult men.

Off‑label or adjunct uses seen in UK specialist practice include short‑term, supervised use after radical prostatectomy and targeted use in psychogenic ED when psychological therapy is concurrent.

Investigational or specialist use for pelvic vascular conditions is occasional and only under urology or vascular specialist supervision.

Fixed combination products pairing vardenafil with dapoxetine are not MHRA‑authorised.

NHS clinics may prescribe vardenafil and dapoxetine as separate medicines when clinically indicated after individual assessment and counselling.

• Licensed Indication: Erectile dysfunction in adult men.
• Off‑Label Use: Post‑radical prostatectomy, selected psychogenic ED under specialist care.
• Unlicensed Combination Products: Products labelled "Levitra Super Force" or similar are unregistered and not authorised.

Prescriptions for expanded uses should follow specialist assessment and documentation, and patients must be counselled on risks and monitoring needs.

Composition And Brand Landscape

What is inside Levitra and what is the market situation for generics and unregulated combos?

The active ingredient is vardenafil (INN) supplied as Levitra by the originator and as multiple generics across European markets.

Levitra tablets are authorised in the UK at strengths 5 mg, 10 mg and 20 mg.

"Levitra Super Force" is not a recognised regulator‑approved brand and is commonly a non‑regulated online combination of 20 mg vardenafil plus 60 mg dapoxetine.

Generics for vardenafil are increasingly available and enter NHS formularies or private supply chains through regional manufacturers and wholesalers.

Patients should check packaging, batch numbers and manufacturer details and buy from GPhC‑registered pharmacies to verify authenticity.

Contraindications And Special Precautions

Who must avoid vardenafil and what precautions should be taken?

Absolute contraindications include concomitant nitrate use and nitric oxide donors due to the risk of severe hypotension.

Other absolute exclusions include severe hepatic impairment, recent stroke or myocardial infarction, unstable angina and known hereditary retinal disorders.

Relative precautions apply for patients with anatomical penile deformities, priapism risk conditions, severe renal impairment and concurrent alpha‑blocker therapy.

• High‑Risk Groups Checklist: Men taking nitrates or amyl nitrite must not take vardenafil.
• Elderly patients and those with liver impairment require dose reduction to limit exposure.
• Patients with sickle cell disease, multiple myeloma or leukaemia need specialist assessment due to priapism risk.
• Report suspected adverse reactions through the MHRA Yellow Card scheme.

Practical patient advice includes avoiding driving if dizziness occurs and limiting alcohol because excess drinking can worsen hypotension and sexual performance.

Dosage Guidelines

What dosing schedule is recommended by the NHS?

Standard on‑demand dosing is 10 mg taken about 60 minutes before sexual activity with adjustment as needed.

Start at 5 mg for elderly patients aged 65 years or over and for those with mild to moderate hepatic impairment.

Increase to 20 mg if necessary and tolerated, not exceeding once daily.

Severe hepatic impairment is a contraindication to use, and dose adjustments are advised in interacting‑drug scenarios.

Missed doses are not applicable given as‑needed use, and overdose symptoms such as severe hypotension or priapism require urgent medical attention.

Seek specialist review if dose escalation fails to achieve satisfactory erectile response after appropriate assessment.

Interactions Overview

Which medicines, foods and drinks interact with vardenafil?

Concomitant nitrates are an absolute contraindication because combined use can precipitate severe hypotension.

Strong CYP3A4 inhibitors such as certain azole antifungals and protease inhibitors raise vardenafil exposure and require dose adjustment or avoidance.

Alpha‑blockers increase the risk of postural hypotension and necessitate careful spacing and titration when both are essential.

Grapefruit juice and other CYP3A4 inhibitors can increase vardenafil levels and therefore the likelihood of adverse effects.

• High‑Risk Interactions: Nitrates (do not co‑prescribe), strong CYP3A4 inhibitors (avoid or reduce dose), alpha‑blockers (monitor carefully).

MHRA Yellow Card reports in the UK commonly note hypotension, dizziness and visual effects as patient‑reported interaction concerns, and suspected interactions should be reported to the Yellow Card scheme.

Cultural Perceptions And Patient Habits

Where do men in the UK seek help and whom do they trust?

Men commonly access NHS sexual‑health clinics or GP services for erectile concerns, with private clinics used for faster access or discretion.

Stigma remains for some men, though online NHS resources and patient forums have reduced barriers to seeking help.

Community pharmacists are highly trusted and often perform initial triage or signpost to clinics for prescriptions and counselling.

• Trusted Sources: NHS 111, local sexual‑health clinics, GPhC‑registered pharmacies (Boots, LloydsPharmacy, Superdrug) and accredited online pharmacies.
• Help‑Seeking Pathways: NHS web advice → GP or sexual‑health referral → prescription via EPS or private e‑prescription.
• Concerns: Authenticity and safety of unregulated online listings such as "Levitra Super Force".

Pharmacist counselling in person or via an online pharmacy consultation increases correct use and reduces risks associated with counterfeit products or unsafe combinations.

Availability And Pricing Patterns

Where can genuine Levitra be obtained in the UK and how much does it cost?

Genuine Levitra (vardenafil tablets 5 mg, 10 mg and 20 mg) is prescription only and stocked by major UK pharmacy chains and sexual‑health clinics.

Online pharmacies with MHRA registration and GPhC‑registered pharmacists may supply vardenafil following a valid prescription with home delivery.

Prescription charging varies across the UK, with standard NHS prescription charges in England and free prescriptions in Scotland, Wales and Northern Ireland creating cost differences for patients.

Private consultation and purchase costs differ between high‑street and online providers, and generics generally reduce price.

Warning: unregulated online sellers frequently market "Levitra Super Force", and such products are unapproved and carry authenticity and safety risks.

In our online pharmacy, levitra super force is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Patient Preferences

How does vardenafil compare with other PDE5 inhibitors and what do patients prefer?

Sildenafil (Viagra) shows similar efficacy with slightly different onset and duration characteristics compared with vardenafil.

Tadalafil (Cialis) has a much longer duration of action, often preferred when sexual activity is less predictable or frequent.

Avanafil (Spedra) has a rapid onset for some patients and can be chosen for quick‑start requirements.

• Sildenafil (Viagra) — well established, similar efficacy; onset somewhat variable.
• Tadalafil (Cialis) — long duration (up to 36 hours); useful for spontaneity.
• Avanafil (Spedra) — faster onset in some users; alternative for those seeking rapid effect.

Choice in NHS prescribing depends on comorbidity, tolerability, cost and patient preference, and many patients trial two agents to identify the best personal fit.

Pharmacists commonly guide switching between agents based on side‑effects, dosing convenience and lifestyle.

FAQ

1. Is "Levitra Super Force" legitimate? No. It is not MHRA or EMA authorised and is typically an unregulated vardenafil plus dapoxetine combination sold online.
2. Do I need a prescription? Yes. Vardenafil and licensed tadalafil or sildenafil products are prescription only in the UK and should be supplied via a GP, sexual‑health clinic or registered online pharmacy.
3. Can I take it with other ED medicines? Never combine PDE5 inhibitors; use one agent at a time and discuss alternatives with your clinician.
4. What if I get a prolonged erection? Priapism lasting longer than four hours is an emergency and requires immediate attendance at A&E or calling NHS 111 for advice.

Guidelines For Proper Use

How should pharmacists counsel patients and which NHS portals can support follow‑up?

Pharmacist counselling should confirm the diagnosis, review cardiovascular history and current medicines, and specifically ask about nitrates and alpha‑blockers before supply.

Advise starting at 10 mg about 60 minutes before sexual activity and explain dose adjustments for elderly or hepatic impairment.

Discuss onset, possible side‑effects and signs that require urgent care such as severe hypotension, sudden visual loss or priapism.

• Counselling Checklist: Check nitrates, review CYP3A4 inhibitors, advise on alcohol, counsel on onset expectations and when to seek emergency care.

NHS support pages, NHS 111 and local sexual‑health clinics are primary referral options, and MHRA Yellow Card reporting should be recommended for suspected adverse reactions.

Electronic prescription service (EPS) details and the need for registered provider verification for private e‑prescriptions should be explained to patients using online pharmacy services.

Patients should be advised to verify manufacturer details and packaging and to avoid unregulated "Super Force" purchases to reduce safety and authenticity risks.

Delivery Across United Kingdom